ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,633, issued on May 19, was assigned to Novartis AG (Basel, Switzerland).

"Antibody molecules to PD-1 and uses thereof" was invented by Sanela Bilic (Urbandale, Iowa), Danny Roland Howard Jr. (Washington, N.J.), John Scott Cameron (Belmont, Mass.) and Glenn Dranoff (Sudbury, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibody molecules that specifically bind to PD-1 are disclosed. The antibody molecules can be used to treat or prevent cancerous or infectious conditions and disorders."

The patent was filed on Dec. 16, 2016, under Application No. 16/062,427.

*For further information, including images, charts and tables, please visit: http://...